🔗 Permalink

Inventor profile of:

Hao Wang

City:

London

Country:

Canada

Published Applications:

Last publication date:

2023-05-25

Top Assignees for applications by Hao Wang

The entities that hold a legal rights for patent applications filed by inventor Wang Hao:

ALEXION PHARMACEUTICALS, INC 3 CHESHIRE, CT United States
iMIRGE Medical INC. 1 London, Canada
Alexion Pharmaceuticals, Inc. 1 New Haven, CT United States

Recent patent applications by Wang Hao

Hao Wang from London, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-05-25

US20230158109A1

Human necessities

USE OF CD83 IN COMBINATION THERAPIES

#2 | 2020-01-30

US20200030038A1

Human necessities

OPTICAL TARGETING AND VISUALIZATION OF TRAJECTORIES

#3 | 2019-10-10

US20190309053A1

Chemistry; metallurgy

PROLONGATION OF SURVIVAL OF AN ALLOGRAFT BY INHIBITING COMPLEMENT ACTIVITY

#4 | 2017-09-21

US20170267751A1

Chemistry; metallurgy

PROLONGATION OF SURVIVAL OF AN ALLOGRAFT BY INHIBITING COMPLEMENT ACTIVITY

#5 | 2016-11-10

US20160324926A1

Human necessities

Use of CD83 in Combination Therapies

#6 | 2016-06-16

US20160166333A1

Human necessities

Optical targeting and visualization of trajectories

#7 | 2016-01-14

US20160008440A1

Human necessities

Use of CD83 in Combination Therapies

#8 | 2014-06-19

US20140170143A1

Chemistry; metallurgy

Use of an anti-CD200 antibody for prolonging the survival of allografts

#9 | 2014-01-09

US20140010821A1

Human necessities

Use of CD83 in combination therapies

#10 | 2010-06-03

US20100135992A1

Chemistry; metallurgy

Prolongation of Survival of an Allograft by Inhibiting Complement Activity

#11 | 2009-01-29

US20090028850A1

Chemistry; metallurgy

Prolongation of survival of an allograft by inhibiting complement activity

InventorID:

604946 ⎘